ArticleJournal of Crohn's & colitis2021
Rechallenge with Subcutaneous Ustekinumab After Hypersensitivity Reaction to Intravenous Ustekinumab.
Sheena Crosby et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it